[1] |
Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.
Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer
[J]. Journal of International Oncology, 2024, 51(6): 332-337.
|
[2] |
Guo Zehao, Zhang Junwang.
Role of PFDN and its subunits in tumorigenesis and tumor development
[J]. Journal of International Oncology, 2024, 51(6): 350-353.
|
[3] |
Xu Fenglin, Wu Gang.
Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma
[J]. Journal of International Oncology, 2024, 51(6): 359-363.
|
[4] |
Gao Fan, Wang Ping, Du Chao, Chu Yanliu.
Research progress on intestinal flora and non-surgical treatment of the colorectal cancer
[J]. Journal of International Oncology, 2024, 51(6): 376-381.
|
[5] |
Fan Zhipeng, Yu Jing, Hu Jing, Liao Zhengkai, Xu Yu, Ouyang Wen, Xie Conghua.
Predictive value of changes in inflammatory markers for prognosis in patients with advanced non-small cell lung cancer treated with the first-line immunotherapy plus chemotherapy
[J]. Journal of International Oncology, 2024, 51(5): 257-266.
|
[6] |
Yang Hao, Shi Guidong, Zhang Chengcheng, Zhang Yue, Zhang Liwen, Fu Maoyong.
Comparison of efficacy and safety between sintilimab and tislelizumab in neoadjuvant therapy for advanced esophageal squamous cell carcinoma
[J]. Journal of International Oncology, 2024, 51(4): 210-216.
|
[7] |
Sa Qiang, Xu Hangcheng, Wang Jiayu.
Advances in immunotherapy for breast cancer
[J]. Journal of International Oncology, 2024, 51(4): 227-234.
|
[8] |
Sun Weiwei, Yao Xuemin, Wang Pengjian, Wang Jing, Jia Jinghao.
Exploration of prognostic factors and nomogram construction for advanced non-small cell lung cancer treated with immunotherapy based on hematologic indexes
[J]. Journal of International Oncology, 2024, 51(3): 143-150.
|
[9] |
Liu Yulan, Jing Haiyan, Sun Jing, Song Wei, Sha Dan.
Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer
[J]. Journal of International Oncology, 2024, 51(3): 175-180.
|
[10] |
Liu Xiaodi, Su Jianfei, Zhang Jingxian, Wei Xueqin, Jia Yingjie.
Research progress of myeloid-derived suppressor cells in tumor angiogenesis
[J]. Journal of International Oncology, 2024, 51(1): 50-54.
|
[11] |
Ye Tongtong, Wu Zeyu, Xi Wenyi, Wang Zhiwei, Jiang Xiaochun, Zhao Chenhui.
Role of ABRACL in the occurrence and development of malignant tumors
[J]. Journal of International Oncology, 2023, 50(9): 544-547.
|
[12] |
Cui Tenglu, Lyu lu, Sun Pengfei.
Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma
[J]. Journal of International Oncology, 2023, 50(9): 548-552.
|
[13] |
Pan Shulan, Liu Chang, He Ping.
Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer
[J]. Journal of International Oncology, 2023, 50(8): 457-462.
|
[14] |
Zhang Yuan, Bai Zhiyu, Li Qi, Feng Qinmei.
Current status of research on exosomes in malignancies
[J]. Journal of International Oncology, 2023, 50(8): 484-488.
|
[15] |
Guo Ciliang, Jiang Chunping, Wu Junhua.
Gut microbiome and tumor immunotherapy
[J]. Journal of International Oncology, 2023, 50(7): 432-436.
|